Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults

Bibliographic Details
Main Authors: Kikuchi, Kayoko, Miyakawa, Yoshitaka, Ikeda, Shunya, Sato, Yuji, Takebayashi, Toru
Format: Online
Language:English
Published: BioMed Central 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307915/
id pubmed-4307915
recordtype oai_dc
spelling pubmed-43079152015-01-28 Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults Kikuchi, Kayoko Miyakawa, Yoshitaka Ikeda, Shunya Sato, Yuji Takebayashi, Toru Research Article BioMed Central 2015-01-22 /pmc/articles/PMC4307915/ /pubmed/25609557 http://dx.doi.org/10.1186/s12913-015-0681-y Text en © Kikuchi et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Kikuchi, Kayoko
Miyakawa, Yoshitaka
Ikeda, Shunya
Sato, Yuji
Takebayashi, Toru
spellingShingle Kikuchi, Kayoko
Miyakawa, Yoshitaka
Ikeda, Shunya
Sato, Yuji
Takebayashi, Toru
Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
author_facet Kikuchi, Kayoko
Miyakawa, Yoshitaka
Ikeda, Shunya
Sato, Yuji
Takebayashi, Toru
author_sort Kikuchi, Kayoko
title Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
title_short Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
title_full Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
title_fullStr Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
title_full_unstemmed Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
title_sort cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults
description
publisher BioMed Central
publishDate 2015
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307915/
_version_ 1613181213710745600